Safety and tolerability of escalating single doses of the hepatitis B virus RNA interference drug ARC- 521 in a healthy volunteer population
Latest Information Update: 07 Jul 2017
At a glance
- Drugs ARC 521 (Primary)
- Indications Unspecified
- Focus Adverse reactions
- 07 Jul 2017 New trial record